TMPRSS2-ERG rearrangement occurs in approximately 50% of prostate cancers and is associated with an aggressive phenotype1  2 Both the TMPRSS2 and ERG genes resides on chromosome 21  and gene rearrangements involving the TMPRSS2 and ERG genes lead to the formation of a TMPRSS2-ERG gene fusion product1  2